Background: Mycophenolate mofetil (MMF) is the prodrug of mycophenolic acid (MPA) which acts as an immunosuppressive agent. During the biotransformation of MMF to MPA, additional metabolites including MPA phenol glucuronide (MPAG), MPA acyl glucuronide (AcMPAG) and MPA phenol glucoside (MPG) are formed. Objective: To define the noncompartmental pharmacokinetic (PK) parameters of three single doses of intravenous (i.v.) MMF and its downstream metabolites in healthy horses. Animals: Six healthy Standardbred mares. Materials and Methods: Generic MMF (Par Pharmaceuticals; Chestnut Ridge, NY, USA) was reconstituted and administered as a single i.v. bolus at 1.0 mg/kg, 5.0 mg/kg and 10.0 mg/kg with an eight day washout between treatments. Blood samples were collected immediately before MMF administration and over 24 h. A liquid chromatography-tandem mass spectrometry assay was developed following FDA guidance to determine plasma MMF, MPA, MPAG, AcMPAG and MPG concentrations. Plasma concentrations were analysed independently, followed by calculation of geometric mean and coefficient of variation. Results: Noncompartmental PK parameters were determined for MMF and all metabolites at all doses. MMF was rapidly converted to MPA in all horses. Each incremental dose of MMF resulted in increases in C max and AUC inf _ obs for MPA and the three additional metabolites. Within the 10-fold dose range, the increase in C max and AUC inf _obs for MMF and its metabolites was nonlinear. Conclusions and clinical relevance: Horses biotransform MMF into MPA, MPAG, AcMPAG and MPG via the glucuronidation and glucosidation clearance pathways. Equine reference PK profiles for MPA and the metabolites, MPAG, AcMPAG and MPG were established.

Dermoscopy is a noninvasive, painless, easy‐to‐perform technique used in human and veterinary medicine for rapid and magnified in vivo observation of dermatological lesions and disease. Dermoscopy can lead to a swifter diagnosis and may eliminate the need to perform more invasive diagnostic testing such as skin biopsies. To perform dermoscopy, the clinician needs a dermoscope and a software program equipped with image capture for pattern identification. Two techniques exist for dermoscopy: standard contact, where the dermoscope is applied directly to the patient's skin with the use of a liquid interface, or noncontact, where there is no direct contact between the skin and the dermoscope. The most important criteria to be considered when using dermoscopy are the morphology/arrangement of vascular structures, scaling patterns, colours, follicular abnormalities and specific disease features. Application of dermoscopic findings should always be correlated with the patient's history, clinical signs and the morphology of the skin lesions. Dermoscopy does require an initial financial and time investment by the clinician, yet this technique can quickly and easily help to identify patterns of disease that correlate with clinical diagnosis of dermatological disease.

A 7‐month‐old, male castrated mixed‐breed pig presented for evaluation of a 3‐month history of cutaneous pigmented nodular lesions, multifocal leukoderma and leukotrichia. Skin biopsies were performed from pigmented nodules and depigmented skin for histopathology. Additional skin biopsies were collected aseptically for bacterial and fungal tissue cultures. Histopathologic diagnosis was a benign melanocytic neoplasm (melanocytoma) and marked vitiligo. Spontaneous regression of melanocytomas did not occur after 1 year of age as previously reported to occur in several swine breeds. Topical imidazoquinoline amine cream was applied to one melanocytoma three times a week for a month. No clinical improvement in either the melanocytoma or vitiligo occurred. In humans, vitiligo is associated with both neoplastic and benign melanocytic neoplasms; this case illustrates the presence of melanoma‐associated leukoderma in a domestic mixed‐breed pig and emphasises the importance of meticulous skin examination in swine patients with the development of vitiligo.